JP2023544446A5 - - Google Patents
Info
- Publication number
- JP2023544446A5 JP2023544446A5 JP2023542830A JP2023542830A JP2023544446A5 JP 2023544446 A5 JP2023544446 A5 JP 2023544446A5 JP 2023542830 A JP2023542830 A JP 2023542830A JP 2023542830 A JP2023542830 A JP 2023542830A JP 2023544446 A5 JP2023544446 A5 JP 2023544446A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- group
- polycyclic
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063081089P | 2020-09-21 | 2020-09-21 | |
| US63/081,089 | 2020-09-21 | ||
| PCT/US2021/051375 WO2022061312A1 (en) | 2020-09-21 | 2021-09-21 | Sik inhibitors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544446A JP2023544446A (ja) | 2023-10-23 |
| JP2023544446A5 true JP2023544446A5 (https=) | 2024-10-01 |
Family
ID=80775691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542830A Pending JP2023544446A (ja) | 2020-09-21 | 2021-09-21 | Ｓｉｋ阻害剤およびその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230265099A1 (https=) |
| EP (1) | EP4213851A4 (https=) |
| JP (1) | JP2023544446A (https=) |
| CN (1) | CN117136061A (https=) |
| AU (1) | AU2021343539A1 (https=) |
| CA (1) | CA3193194A1 (https=) |
| WO (1) | WO2022061312A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4526307A1 (en) * | 2022-05-17 | 2025-03-26 | Soltego, Inc. | Pyrimidopyrimidone compounds and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104418860B (zh) * | 2013-08-20 | 2016-09-07 | 中国科学院广州生物医药与健康研究院 | 嘧啶并杂环类化合物及其药用组合物和应用 |
| WO2018009544A1 (en) * | 2016-07-05 | 2018-01-11 | The Broad Institute, Inc. | Bicyclic urea kinase inhibitors and uses thereof |
| US11241435B2 (en) * | 2016-09-16 | 2022-02-08 | The General Hospital Corporation | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis |
| AU2018226771B2 (en) * | 2017-02-28 | 2023-11-23 | Dana-Farber Cancer Institute, Inc. | Uses of pyrimidopyrimidinones as SIK inhibitors |
| CA3124574A1 (en) * | 2018-12-28 | 2020-07-02 | Spv Therapeutics Inc. | Cyclin-dependent kinase inhibitors |
| AU2021262482A1 (en) * | 2020-04-28 | 2023-01-05 | Iomx Therapeutics Ag | Bicyclic kinase inhibitors and uses thereof |
-
2021
- 2021-09-21 US US18/027,556 patent/US20230265099A1/en active Pending
- 2021-09-21 JP JP2023542830A patent/JP2023544446A/ja active Pending
- 2021-09-21 WO PCT/US2021/051375 patent/WO2022061312A1/en not_active Ceased
- 2021-09-21 CA CA3193194A patent/CA3193194A1/en active Pending
- 2021-09-21 CN CN202180078421.4A patent/CN117136061A/zh active Pending
- 2021-09-21 EP EP21870430.2A patent/EP4213851A4/en active Pending
- 2021-09-21 AU AU2021343539A patent/AU2021343539A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI832361B (zh) | 具有高口服生物利用度的ｊａｋ抑制劑 | |
| CN109963854A (zh) | 杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用 | |
| CN106458930B (zh) | 2-氨基嘧啶类化合物及其药物组合物和应用 | |
| CN114072396A (zh) | 作为dna-pk抑制剂的喹啉和噌啉衍生物 | |
| JP2013056930A5 (https=) | ||
| JP2013509431A5 (https=) | ||
| JP2009513703A5 (https=) | ||
| CN113365998A (zh) | 用于parp抑制剂的吲哚并七元酰肟类似物 | |
| JP2021502387A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2019524883A5 (https=) | ||
| JP2019510787A5 (https=) | ||
| JP2022501429A5 (https=) | ||
| JP2020512337A5 (https=) | ||
| JP2020506895A5 (https=) | ||
| JP2016525104A5 (https=) | ||
| CN111601797A (zh) | 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用 | |
| CN115697992A (zh) | 一种能够抑制并降解雄激素受体的化合物及其药物组合物和药学上的应用 | |
| CN111511745A (zh) | 吡唑并[1,5-a][1,3,5]三嗪-2-胺类衍生物、其制备方法及其在医药上的应用 | |
| US9738613B2 (en) | Substituted 1,2,3-triazoles as antitumor agents | |
| WO2017202311A1 (zh) | 一种2-氨基嘧啶类化合物的多晶型形式 | |
| JP2024542881A5 (https=) | ||
| JP2023544446A5 (https=) | ||
| JP2005538974A5 (https=) | ||
| JP2007513872A5 (https=) |